Methods for purifying cells derived from pluripotent stem cells
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/071
A61K-035/39
출원번호
US-0036476
(2011-02-28)
등록번호
US-9969981
(2018-05-15)
발명자
/ 주소
Karanu, Francis
Rezania, Alireza
출원인 / 주소
Janssen Biotech, Inc.
대리인 / 주소
Gianneschi, Lois A.
인용정보
피인용 횟수 :
0인용 특허 :
78
초록▼
The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention provides methods of characterization of cells differentiated into cells expressing markers characteristic of the pancreatic endocrine lineage utilizing unique surface markers. T
The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention provides methods of characterization of cells differentiated into cells expressing markers characteristic of the pancreatic endocrine lineage utilizing unique surface markers. The present invention also provides methods to enrich or sort cells expressing markers characteristic of the pancreatic endocrine lineage. The present invention also provides methods to deplete cells that may contaminate populations of cells expressing markers characteristic of the pancreatic endocrine lineage formed by the methods of the present invention, thereby reducing the incidence of tumor formation in vivo following transplantation.
대표청구항▼
1. A method to produce a population of pancreatic endocrine precursor cells enriched for NeuroD, NGN3, PDX-1, and NKX6.1 comprising the steps of: a) differentiating a population of human pluripotent stem cells into definitive endoderm cells by treating the pluripotent stem cells with a culture mediu
1. A method to produce a population of pancreatic endocrine precursor cells enriched for NeuroD, NGN3, PDX-1, and NKX6.1 comprising the steps of: a) differentiating a population of human pluripotent stem cells into definitive endoderm cells by treating the pluripotent stem cells with a culture medium supplemented with activin A;b) differentiating the definitive endoderm cells into a population of pancreatic endocrine precursor cells;c) selecting pancreatic endocrine precursor cells; andd) enriching the population of pancreatic endocrine precursor cells for NeuroD, NGN3, PDX-1, and NKX6.1 by screening the population of cells for one of the following surface markers or surface marker combinations to thereby produce an enriched population of cells that is negative for CD13 and: 1) positive for CD56,2) positive for CD56 and CD15lo, or3) positive for both CD56 and CD57. 2. The method of claim 1, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for CD56 and negative for CD13. 3. The method of claim 1, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for CD56 and CD15lo. 4. The method of claim 1, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for positive for both CD56 and CD57. 5. A method to produce a population of pancreatic endocrine precursor cells enriched for NeuroD, NGN3, PDX-1, and NKX6.1 comprising the steps of: a) differentiating a population of human pluripotent stem cells into definitive endoderm cells by treating the pluripotent stem cells with a culture medium supplemented with activin A;b) differentiating the definitive endoderm cells into a population of pancreatic endocrine precursor cells; andc) enriching the population of pancreatic endocrine precursor cells for NeuroD, NGN3, PDX-1, and NKX6.1 by screening the population of cells for cells that are positive for CD56 and CD57, and negative for CD13. 6. A method of enriching a population of pancreatic endocrine precursor cells for NeuroD, NGN3, PDX-1, and NKX6.1 by screening the population of cells for one of the following surface markers or surface marker combinations to thereby produce an enriched population of cells that is negative for CD13 and: 1) positive for CD56,2) positive for CD56 and CD15lo, or3) positive for both CD56 and CD57. 7. The method of claim 6, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for CD56 and negative for CD13. 8. The method of claim 6, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for CD56 and CD15lo. 9. The method of claim 6, wherein the population of pancreatic endocrine precursor cells is screened for cells that are positive for positive for both CD56 and CD57. 10. The method of claim 6, wherein the pancreatic endocrine precursor cells are derived by in vitro differentiation of human pluripotent stem cells. 11. A method of generating pancreatic endocrine cells comprising: obtaining a population of pancreatic endocrine precursor cells enriched for NeuroD, NGN3, PDX-1, and NKX6.1 using the method of claim 1; anddifferentiating the pancreatic endocrine precursor cells into pancreatic endocrine cells. 12. A method of generating pancreatic endocrine cells comprising: obtaining a population of pancreatic endocrine precursor cells enriched for NeuroD, NGN3, PDX-1, and NKX6.1 using the method of claim 6; anddifferentiating the pancreatic endocrine precursor cells into pancreatic endocrine cells.
Yi, Chin-Feng; Gosiewska, Anna; Roweton, Susan, Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering.
Coon Hayden G. ; Ambesi-Impiombato Francesco Saverio,ITX ; Curcio Francesco,ITX, Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells.
Chatelier Ronald C. (9 Apple Gve Bayswater ; Victoria 3168 AUX) Griesser Hans J. (20 View Road The Patch ; Victoria 3792 AUX) Steele John G. (7 The Carriageway North Rocks ; NSW 2151 AUX) Johnson Gra, Cell growth substrates.
Vyakarnam Murty N. ; Zimmerman Mark C. ; Scopelianos Angelo George ; Chun Iksoo ; Melican Mora C. ; Bazilio Clairene A. ; Roller Mark B. ; Gorky David V., Foam composite for the repair or regeneration of tissue.
Vacanti Joseph P. (Winchester MA) Freeman Michael R. (Boston MA), Genitourinary cell-matrix structure for implantation into a human and a method of making.
Evans Ronald M. (San Diego CA) Rosenfeld Michael G. (San Diego CA) Cerelli Gail (Cardiff CA) Mayo Kelly E. (Wilmette IL) Spiess Joachim (Encinitas CA) Rivier Jean E. F. (La Jolla CA) Vale ; Jr. Wylie, Human inhibin.
McIntosh Kevin R. ; Mosca Joseph D. ; Klyushnenkova Elena N., Mesenchymal stem cells for prevention and treatment of immune responses in transplantation.
Bryhan, Marie D.; Gagnon, Paul E.; LaChance, Oliva V.; Shen, Zhong-he; Wang, Hongming, Method for creating a cell growth surface on a polymeric substrate.
Bodnar, Andrea G.; Chiu, Choy-Pik; Gold, Joseph D.; Inokuma, Margaret; Murai, James T.; West, Michael D., Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture.
Dalton, Stephen; Sheppard, Allan; Jones, Karen; Baetge, E. Edward; D'Amour, Kevin A.; Agulnick, Alan D., Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors.
Mason Anthony J. (San Francisco CA) Seeburg Peter H. (Heidelberg DEX), Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic aci.
Mason Anthony J. ; Seeburg Peter H., Nucleic acid encoding the mature .beta..sub.B chain of inhibin and method for synthesizing polypeptides using such nucl.
Mason Anthony J. (San Francisco CA) Seeburg Peter H. (San Francisco CA), Nucleic acid encoding the mature a
상세보기
Mason Anthony J. (San Francisco CA) Seeburg Peter H. (San Francisco CA), Nucleic acid encoding the mature bAchain of inhibin and method for synthesizing.
Vyakarnam Murty N. ; Zimmerman Mark C. ; Scopelianos Angelo George ; Roller Mark B. ; Gorky David V., Porous tissue scaffoldings for the repair of regeneration of tissue.
Murty N. Vyakarnam ; Mark C. Zimmerman ; Angelo George Scopelianos ; Mark B. Roller ; David V. Gorky, Porous tissue scaffoldings for the repair or regeneration of tissue.
Vyakarnam, Murty N.; Zimmerman, Mark C.; Scopelianos, Angelo George; Roller, Mark B.; Gorky, David V., Porous tissue scaffoldings for the repair or regeneration of tissue.
Mistry,Sanjay; Kihm,Anthony J.; Harris,Ian Ross; Harmon,Alexander M.; Messina,Darin J.; Yi,Chin Feng; Gosiewska,Anna, Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same.
MacMichael Donald Bruce Atherton,GBX ; Drake David,GBX ; Arlington Stephen Adrian,GBX ; Normansell Ian David,GBX ; Addicott John Kenneth,GBX ; Divers Moira Sloan,GBX ; Stovold John Spencer,GBX, Process and apparatus for cell sorting.
Melican, Mora Carolynne; Li, Yufu; Brown, Kelly R.; Chun, Iksoo; McAllen, III, John; Rezania, Alireza; Scopelianos, Angelo G.; Vyakarnam, Murty N., Reinforced tissue implants and methods of manufacture and use.
Mistry,Sanjay; Messina,Darin J.; Harris,Ian Ross; Harmon,Alexander M.; Seyda,Agnieszka; Yi,Chin Feng; Gosiewska,Anna, Treatment of retinitis pigmentosa with human umbilical cord cells.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.